Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28298405 | 0.91 | LMNA (0.67) | TSHRLMNAKMT2AMEN1MAPT | |
| SCHEMBL72471 | 0.89 | LMNA (0.62) | TSHRLMNAMAPTHTTALDH1A1 | |
| SCHEMBL13800475 | 0.89 | LMNA (0.70) | TSHRLMNAKMT2AMEN1MAPT | |
| SCHEMBL31402602 | 0.87 | LMNA (0.60) | TSHRLMNAMAPTHTTALDH1A1 | |
| SCHEMBL2914094 | 0.83 | TSHR (0.62) | TSHRLMNAKMT2AMEN1MAPT | |
| Dimethyl Succinate SCHEMBL28197342 | 0.82 | TSHR (0.54) | TSHRLMNAKMT2AMEN1MAPT | |
| Dimethyl Succinate SCHEMBL28197354 | 0.82 | TSHR (0.58) | TSHRLMNAKMT2AMEN1MAPT | |
| SCHEMBL1983440 | 0.82 | MGAM (0.48) | TSHRLMNAKMT2AMEN1MAPT | |
| Butane SCHEMBL20558824 | 0.82 | LMNA (0.68) | TSHRLMNAMAPTHTTALDH1A1 | |
| SCHEMBL25182 | 0.82 | LMNA (0.56) | TSHRLMNAMAPTKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118510877-A | Cleaning composition for pretreatment of metal substrates, method for the production thereof and use thereof | 巴斯夫涂料有限公司 | 2024-08-16 | — | — | CN | disclosed |
| WO-2023131530-A1 | A CLEANING COMPOSITION FOR METAL SUBSTRATES PRETREATMENT AND ITS PREPARATION METHOD AND APPLICATION THEREOF | BASF COATINGS GMBH (DE) | 2023-07-13 | — | — | WO | disclosed |
| WO-2022138541-A1 | POLYMETALLOXANE, COMPOSITION OF SAME, CURED FILM, METHOD FOR PRODUCING SAID CURED FILM, MEMBER AND ELECTRONIC COMPONENT EACH PROVIDED WITH SAID CURED FILM, FIBER, AND METHOD FOR PRODUCING SAID FIBER | 東レ株式会社 | 2022-06-30 | — | — | WO | disclosed |
| US-9545104-B2 | Liquid suspension concentrate formulations containing saflufenacil and glyphosate | BASF SE (DE) | 2017-01-17 | — | — | US | disclosed |
| CN-102655748-B | Liquid suspension concentrate preparaton containing benzene flumetsulam | BASF SE (DE) | 2015-11-25 | — | — | CN | disclosed |
| CN-102651971-B | Liquid suspension concentrate formulations containing saflufenacil and glyphosate | BASF SE | 2015-05-13 | — | — | CN | disclosed |
| US-8741809-B2 | Liquid pyraclostrobin-containing crop protection formulations | BASF SE (DE) | 2014-06-03 | — | — | US | disclosed |
| US-8716182-B2 | Liquid aqueous crop protection formulations | BASF SE (DE) | 2014-05-06 | — | — | US | disclosed |
| US-8703650-B2 | Liquid suspension concentrate formulations containing saflufenacil | BASF SE (DE) | 2014-04-22 | — | — | US | disclosed |
| US-20120302444-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL | BASF SE (DE) | 2012-11-29 | — | — | US | disclosed |
| EP-0218693-A1 | CYCLOPENTADIENE DERIVATIVES AND THEIR METHOD OF PREPARATION | ASHLAND OIL, INC. (US) | 1987-04-22 | — | — | EP | disclosed |
| US-4636537-A | CURABLE BINDER CONTAINING CYCLOPENTADIENE DERIVATIVES | ASHLAND OIL, INC. (US) | 1987-01-13 | — | — | US | disclosed |
| WO-1986006083-A1 | CYCLOPENTADIENE DERIVATIVES, METHOD OF PREPARATION AND METHOD OF USE | ASHLAND OIL, INC. (US) | 1986-10-23 | — | — | WO | disclosed |
| US-4483961-A | Polymeric cyclopentadiene derivatives, method for preparing and use thereof | ASHLAND OIL, INC. (US) | 1984-11-20 | — | — | US | disclosed |
| US-4482653-A | Cyclopentadiene derivatives, method for preparing, and use thereof | ASHLAND OIL, INC. (US) | 1984-11-13 | — | — | US | disclosed |
| US-4464521-A | EPOXIDIZED FULVENES AS BINDER FOR AGGREGATE; FOUNDRY BINDERS | ASHLAND OIL, INC. (US) | 1984-08-07 | — | — | US | disclosed |
| US-4412088-A | CURABLE BINDER COMPOSITIONS | ASHLAND OIL, INC. (US) | 1983-10-25 | — | — | US | disclosed |
| US-4390675-A | EPOXYFULVENE, ACID CATALYST | ASHLAND OIL, INC. (US) | 1983-06-28 | — | — | US | disclosed |
| US-4220578-A | Method, resin and catalyst for increasing the tensile strength and core hardness of a sand mold or core | CL INDUSTRIES INC. (US) | 1980-09-02 | — | — | US | disclosed |
| US-4215012-A | SULFUR-FREE; DIALKYL ESTER COMPOUND AND A LEWIS ACID, POLYMERIZATION CATALYST | C L INDUSTRIES, INC. (US) | 1980-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302444-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL | SCD5, FFAR3, FFAR2 | TSHR 2738/4885LMNA 402/4885KMT2A 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.